GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 15 filers reported holding GAIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,237 | -35.6% | 8,304 | -12.1% | 0.00% | – |
| Q2 2023 | $42,322 | +104.0% | 9,447 | +119.4% | 0.00% | – |
| Q1 2023 | $20,750 | -9.1% | 4,305 | -40.9% | 0.00% | – |
| Q4 2022 | $22,815 | +75.5% | 7,289 | +76.8% | 0.00% | – |
| Q3 2022 | $13,000 | -43.5% | 4,122 | -35.7% | 0.00% | – |
| Q2 2022 | $23,000 | +35.3% | 6,411 | +56.4% | 0.00% | – |
| Q1 2022 | $17,000 | -70.2% | 4,100 | -60.9% | 0.00% | – |
| Q4 2021 | $57,000 | +11.8% | 10,497 | +55.7% | 0.00% | – |
| Q3 2021 | $51,000 | +24.4% | 6,740 | +64.4% | 0.00% | – |
| Q2 2021 | $41,000 | -54.9% | 4,100 | -32.8% | 0.00% | – |
| Q1 2021 | $91,000 | – | 6,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 151,132 | $807,000 | 1.04% |
| CM Management, LLC | 90,000 | $489,000 | 0.37% |
| Greenlight Capital | 546,560 | $2,968,000 | 0.17% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $267,000 | 0.01% |
| Veritable, L.P. | 25,064 | $136,000 | 0.00% |
| Banque Cantonale Vaudoise | 3,000 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,056 | $107,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,754 | $84,000 | 0.00% |
| MORGAN STANLEY | 800 | $4,000 | 0.00% |